COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know: https://www.cancer.gov/coronavirus

Guidance for cancer researchers: https://www.cancer.gov/coronavirus-researchers

Get the latest public health information from CDC: https://www.coronavirus.gov

Get the latest research information from NIH: https://www.nih.gov/coronavirus

Mathangi Thiagarajan, M.S.

Project Director, Biospecimen Research Group, Frederick National Laboratory for Cancer Research

Mathangi Thiagarajan

Mathangi Thiagarajan manages the biospeciman collection compnent of the CPTAC program for the Frederick National Lab for Cancer Reserach supporting the National Cancer Institute.  Prior to this role, she managed the genomic contrats for the CPTAC program, CPTAC phase II biospeciman collection and Cancer Genomics HUB (a genomic data repository for the TCGA program).  Ms. Thiagarajan received her M.S in Biomedical informatics with a specialization in genomics and bioinformatics from the University of Medicine and Dentistry of New Jersey (UMDNJ), and M.Sc. in Biochemistry from India.  Ms. Thiagarajan was a scientific and technical lead for over a decade at the J. Craig Venter Institute in charge of several genome projects prior to supporting the National Cancer Institute. She has authored over 25 scientific research papers and has presented at numerous scientific conferences. She is a PMI certified project management professional (PMP).